Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MCK Stock Forecast 2025-2026
$808.62
Current Price
$100.58B
Market Cap
Buy 12
Hold 3
Sell 1
Wall St Analyst Ratings
Distance to MCK Price Targets
+23.7%
To High Target of $1,000.00
+18.4%
To Median Target of $957.50
-6.0%
To Low Target of $760.00
MCK Price Momentum
-8.2%
1 Week Change
-5.1%
1 Month Change
+34.0%
1 Year Change
+41.9%
Year-to-Date Change
-9.7%
From 52W High of $895.58
+44.9%
From 52W Low of $558.13
📊 TOP ANALYST CALLS
Did MCK Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if McKesson is one of their latest high-conviction picks.
Latest MCK Stock Price Targets & Analyst Predictions
Based on our analysis of 26 Wall Street analysts, MCK has a bullish consensus with a median price target of $957.50 (ranging from $760.00 to $1,000.00). The overall analyst rating is Strong Buy (8.6/10). Currently trading at $808.62, the median forecast implies a 18.4% upside. This outlook is supported by 12 Buy, 3 Hold, and 1 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MCK Analyst Ratings
12
Buy
3
Hold
1
Sell
MCK Price Target Range
Low
$760.00
Average
$957.50
High
$1,000.00
Current: $808.62
Latest MCK Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MCK.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 10, 2025 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $914.00 |
| Nov 6, 2025 | UBS | Kevin Caliendo | Buy | Maintains | $980.00 |
| Nov 6, 2025 | Baird | Eric Coldwell | Outperform | Maintains | $927.00 |
| Nov 6, 2025 | Morgan Stanley | Erin Wright | Overweight | Maintains | $916.00 |
| Oct 27, 2025 | UBS | Kevin Caliendo | Buy | Maintains | $920.00 |
| Oct 14, 2025 | Jefferies | Brian Tanquilut | Buy | Maintains | $900.00 |
| Sep 26, 2025 | JP Morgan | Lisa Gill | Overweight | Maintains | $853.00 |
| Sep 24, 2025 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $816.00 |
| Sep 24, 2025 | Mizuho | Steven Valiquette | Neutral | Maintains | $770.00 |
| Sep 24, 2025 | Deutsche Bank | George Hill | Buy | Maintains | $856.00 |
| Sep 24, 2025 | Leerink Partners | Michael Cherny | Outperform | Maintains | $850.00 |
| Sep 24, 2025 | Evercore ISI Group | Elizabeth Anderson | Outperform | Maintains | $825.00 |
| Sep 24, 2025 | Citigroup | Daniel Grosslight | Buy | Maintains | $860.00 |
| Sep 24, 2025 | TD Cowen | Charles Rhyee | Buy | Maintains | $864.00 |
| Sep 24, 2025 | Morgan Stanley | Erin Wright | Overweight | Maintains | $857.00 |
| Sep 24, 2025 | B of A Securities | Michael Cherny | Buy | Maintains | $850.00 |
| Sep 24, 2025 | UBS | Kevin Caliendo | Buy | Maintains | $860.00 |
| Aug 13, 2025 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $772.00 |
| Jul 16, 2025 | Morgan Stanley | Erin Wright | Overweight | Maintains | $810.00 |
| Jul 9, 2025 | Evercore ISI Group | Elizabeth Anderson | Outperform | Maintains | $800.00 |
McKesson Corporation (MCK) Competitors
The following stocks are similar to McKesson based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
McKesson Corporation (MCK) Financial Data
McKesson Corporation has a market capitalization of $100.58B with a P/E ratio of 25.3x. The company generates $387.09B in trailing twelve-month revenue with a 1.0% profit margin.
Revenue growth is +10.1% quarter-over-quarter, while maintaining an operating margin of +1.4% and return on equity of -194.5%.
Valuation Metrics
Market Cap
$100.58B
Enterprise Value
$106.92B
P/E Ratio
25.3x
PEG Ratio
0.1x
Price/Sales
0.3x
Growth & Margins
Revenue Growth (YoY)
+10.1%
Gross Margin
+3.4%
Operating Margin
+1.4%
Net Margin
+1.0%
EPS Growth
+360.6%
Financial Health
Cash/Price Ratio
+4.0%
Current Ratio
0.9x
Debt/Equity
-17.2x
ROE
-194.5%
ROA
+4.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
McKesson Corporation (MCK) Business Model
About McKesson Corporation
What They Do
Healthcare services and information technology provider.
Business Model
McKesson generates revenue by distributing pharmaceuticals and medical products to pharmacies, hospitals, and healthcare facilities. It also offers specialized software and automated solutions that enhance operational efficiency in the healthcare sector.
Additional Information
With a significant market presence in North America, McKesson plays a critical role in shaping healthcare logistics and innovation, ensuring that healthcare supply networks are reliable and responsive to industry demands.
Company Information
Sector
Healthcare
Industry
Medical Distribution
Employees
43,000
CEO
Mr. Brian S. Tyler Ph.D.
Country
United States
IPO Year
1994
Website
www.mckesson.comMcKesson Corporation (MCK) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Why Is McKesson (MCK) Down 5.2% Since Last Earnings Report?
McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Dec 05, 2025
By Zacks Equity Research
Realtime BLOG
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Nov 28, 2025
By Zacks Equity Research
Tale of the Tape
Here's Why McKesson (MCK) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Nov 27, 2025
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
McKesson (MCK) reported earnings 30 days ago; investors should monitor upcoming developments and market reactions for potential stock movements.
Why It Matters
Upcoming stock performance for McKesson depends on earnings trends and market reactions, influencing investor sentiment and potential price movements.
Source: Zacks Investment Research
Market Sentiment:
Negative
McKesson Corporation (MCK) Presents at Evercore 8th Annual Healthcare Conference Transcript
2 days ago
Quick Summary
McKesson Corporation (MCK) participated in the Evercore 8th Annual Healthcare Conference, discussing key topics relevant to investors and the healthcare sector.
Why It Matters
McKesson's presentation could signal strategic insights or future growth plans, impacting stock performance and investor sentiment in the healthcare sector.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
McKesson released its inaugural Advancing Community Oncology Report, highlighting trends affecting community oncology practices nationwide.
Why It Matters
McKesson's report on community oncology trends may indicate strategic shifts in healthcare, impacting market dynamics and investment opportunities in related sectors.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
McKesson (MCK) is currently attracting attention from Zacks.com users, indicating potential investor interest. Key factors influencing its stock prospects are worth noting.
Why It Matters
Increased interest in McKesson suggests potential volatility or opportunity, prompting investors to analyze fundamentals and market trends that could impact stock performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Zacks Style Scores can help investors identify strong, market-beating stocks for their portfolios.
Why It Matters
The Zacks Style Scores can help investors identify high-potential stocks, potentially leading to better portfolio performance and increased returns.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Analyst recommendations from brokerage firms can significantly impact stock prices, influencing investor decisions on buying, selling, or holding stocks.
Why It Matters
Analyst recommendations can significantly sway stock prices, impacting investor sentiment and trading decisions, thereby affecting market trends and valuations.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About MCK Stock
What is McKesson Corporation's (MCK) stock forecast for 2026?
Based on our analysis of 26 Wall Street analysts, McKesson Corporation (MCK) has a median price target of $957.50. The highest price target is $1,000.00 and the lowest is $760.00.
Is MCK stock a good investment in 2026?
According to current analyst ratings, MCK has 12 Buy ratings, 3 Hold ratings, and 1 Sell ratings. The stock is currently trading at $808.62. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MCK stock?
Wall Street analysts predict MCK stock could reach $957.50 in the next 12 months. This represents a 18.4% increase from the current price of $808.62. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is McKesson Corporation's business model?
McKesson generates revenue by distributing pharmaceuticals and medical products to pharmacies, hospitals, and healthcare facilities. It also offers specialized software and automated solutions that enhance operational efficiency in the healthcare sector.
What is the highest forecasted price for MCK McKesson Corporation?
The highest price target for MCK is $1,000.00 from at , which represents a 23.7% increase from the current price of $808.62.
What is the lowest forecasted price for MCK McKesson Corporation?
The lowest price target for MCK is $760.00 from at , which represents a -6.0% decrease from the current price of $808.62.
What is the overall MCK consensus from analysts for McKesson Corporation?
The overall analyst consensus for MCK is bullish. Out of 26 Wall Street analysts, 12 rate it as Buy, 3 as Hold, and 1 as Sell, with a median price target of $957.50.
How accurate are MCK stock price projections?
Stock price projections, including those for McKesson Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: December 7, 2025 10:16 AM UTC